{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:41:24Z","timestamp":1790318484194,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.jcv.2004.05.016","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T14:20:05Z","timestamp":1092406805000},"page":"275-282","source":"Crossref","is-referenced-by-count":69,"title":["Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry"],"prefix":"10.1016","volume":"31","author":[{"given":"Tzong-Hae","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Chafets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2004.05.016_BIB1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0166-0934(98)00087-1","article-title":"Quantification of human T cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction","volume":"75","author":"Albrecht","year":"1998","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2004.05.016_BIB2","unstructured":"American type culture collection (ATCC), Manassas, VA. ATCC number: CRL-8066."},{"key":"10.1016\/j.jcv.2004.05.016_BIB3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-0934(01)00445-1","article-title":"Quantitation of HTLV-I proviral load by a TaqMan real time PCR assay","volume":"102","author":"Dehee","year":"2002","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2004.05.016_BIB4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0890-8508(03)00002-1","article-title":"Multiplex PCR using real time DNA amplification for the rapid detection and quantitation of HTLV I or II","volume":"17","author":"Estes","year":"2003","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.jcv.2004.05.016_BIB5","unstructured":"Gebretsadik T, Murphy EL. Counseling and medical evaluation of HTLV-I and HTLV-II infected patients. AIDS Clin Rev 1993\u201394;19\u201341."},{"issue":"10","key":"10.1016\/j.jcv.2004.05.016_BIB6","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.jcv.2004.05.016_BIB7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4269\/ajtmh.1994.51.11","article-title":"Prevalence of Human T cell lymphotropic virus type II in American Indian populations of the southwestern United States","volume":"51","author":"Hjelle","year":"1994","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"10.1016\/j.jcv.2004.05.016_BIB8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJM199202063260604","article-title":"Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases","volume":"326","author":"Khabbaz","year":"1992","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.jcv.2004.05.016_BIB9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1537-2995.1991.31191096189.x","article-title":"The epidemiology of the human T cell lymphotrophic virus type I and type II: etiologic role in human disease","volume":"31","author":"Manns","year":"1991","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.jcv.2004.05.016_BIB10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/088922200308891","article-title":"Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load","volume":"16","author":"Miley","year":"2000","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jcv.2004.05.016_BIB11","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/archinte.159.13.1485","article-title":"Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type II-and I-infected blood donors","volume":"159","author":"Murphy","year":"1999","journal-title":"Arch. Intern. Med"},{"key":"10.1016\/j.jcv.2004.05.016_BIB12","unstructured":"Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D. Higher HTLV proviral load is associated with HTLV-I\/II versus HTLV-II, HTLV-II subtype A versus B, and with male sex and a history of blood transfusion. J Infect Dis [in press]."},{"key":"10.1016\/j.jcv.2004.05.016_BIB13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/13550289809114225","article-title":"Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP","volume":"4","author":"Nagai","year":"1998","journal-title":"J. Neurovirol"},{"key":"10.1016\/j.jcv.2004.05.016_BIB14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1349-7006.1998.tb03262.x","article-title":"Provirus load in patients with human T cell leukemia virus type I uveitis correlates with precedent Grave\u2019s disease and disease activities","volume":"89","author":"Ono","year":"1998","journal-title":"Jpn. J. Cancer Res"},{"key":"10.1016\/j.jcv.2004.05.016_BIB15","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/01.WNL.0000096011.92542.DA","article-title":"Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study","volume":"61","author":"Orland","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jcv.2004.05.016_BIB16","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM200003303421304","article-title":"HTLV-II-associated cutaneous T cell lymphoma in a patient with HIV-1 infection","volume":"342","author":"Poiesz","year":"2000","journal-title":"N. Engl. J. Med"},{"issue":"12","key":"10.1016\/j.jcv.2004.05.016_BIB17","doi-asserted-by":"crossref","first-page":"10289","DOI":"10.1128\/JVI.73.12.10289-10295.1999","article-title":"Effect of lamivudine on human T cell leukemia virus type 1 (HTLV-1) DNA copy number, T cell phenotype, and anti-tax cytotoxic T cell frequency in patients with HTLV-1-associated myelopathy","volume":"73","author":"Taylor","year":"1999","journal-title":"J. Virol"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653204001672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653204001672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:02:48Z","timestamp":1585872168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653204001672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S1386653204001672"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2004.05.016","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}